Abilify and Compulsive Behavior

Determined Injury Attorneys Assist Victims of Abilify Compulsive Behavior

Holding manufacturers accountable for economic losses due to side effects

If you or a loved one has been taking the drug aripiprazole, marketed under the names Abilify, Abilify Maintena , Aristada, Rexulti and various generics, you should be aware that many users of these drugs have developed costly compulsive behaviors that caused extreme financial losses. Fortunately, lawsuits against Bristol-Myers Squibb, the drug’s manufacturer, have been successful in proving the company’s liability for these behaviors and holding the company accountable for patients’ financial losses. At Marcari, Russotto, Spencer & Balaban, we are pursuing justice for victims of Abilify’s compulsive-behavior side effects. If you have been harmed, we are determined to see that you are fully compensated.

Background of Abilify lawsuits for compulsive-behavior side effects

Abilify is an antipsychotic drug used to treat schizophrenia, bipolar disorder, Tourette syndrome, and irritability associated with autistic disorder, among other conditions. On May 3, 2016, the U.S. Food and Drug Administration (FDA) issued a communication warning about impulse-control problems in patients taking the various forms of Abilify. The FDA warned that patients might experience uncontrollable urges “to gamble, binge eat, shop, and have sex.”

The FDA cited 167 U.S. cases from its Adverse Event Reporting System database and medical literature showing compulsive behavior since the drug’s approval in 2002. “Pathological gambling was the most common (164 cases), but other compulsive behaviors including compulsive eating, spending or shopping, and sexual behaviors were also reported.” The agency noted there may be more cases than those reported, especially since about “1.6 million patients received an aripiprazole prescription from U.S. outpatient retail pharmacies during 2015.”

This mass tort has prompted hundreds of lawsuits against Bristol-Myers Squibb and its marketing partner, Otsuka Pharmaceutical Co., alleging the companies knew about the defect in the drug that caused compulsive behavior but did not issue adequate warning to protect patients. Plaintiffs also allege the companies failed to properly test the drug, exaggerated its benefits, and encouraged physicians to prescribe the drug for unapproved conditions. Currently, more than 400 lawsuits have been filed in federal courts claiming Abilify caused compulsive gambling that was financially ruinous to the victim.

Damages available in an Abilify lawsuit

Personal injury law allows a victim to recover economic and noneconomic damages when a defective product causes harm. If you have been harmed by Abilify, you may be able to recover full compensation, which can include:

  • Present and future medical bills
  • Present and future wage losses directly caused by the compulsive behavior
  • Gambling losses
  • Other economic losses due to compulsive behavior
  • Pain and suffering

If a manufacturer’s conduct is found to be particularly egregious, plaintiffs in defective product lawsuits might also recover punitive damages, intended to punish the company rather than compensate the victim.

If you started using Abilify prior to May 3, 2016, developed a problem with compulsive gambling, day trading or shopping, and lost more than $5,000, our attorneys with Marcari, Russotto, Spencer & Balaban are determined to help you recover the full compensation you deserve.

Contact our mass tort lawyers to pursue compensation in your Abilify case

If you used Abilify and developed a compulsive gambling problem with documented losses totaling more than $5,000, Marcari, Russotto, Spencer & Balaban is prepared to fight for your full compensation. Call us today at (877) 428-1122 or contact us online to schedule a free consultation. For your convenience, we have offices throughout North Carolina, South Carolina & Virginia.